FDA Inspection 1206879 — MUDr. Petr Kasalicky
The FDA completed an inspection of MUDr. Petr Kasalicky on April 28, 2023 in Prague. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- April 28, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Prague (Czech Republic)
Additional Details
Clinical Investigator (CI)